Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.34

-0.02 (-5.29%)

At close: May 02, 2025, 3:59 PM

0.38

11.59%

After-hours: May 02, 2025, 05:56 PM EDT

Aspire BioPharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Net Income	-8.93M	-243.63K	-96.92K	-163.87K	-76.78K	-65.53K	-90.27K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	1.22M	-290.17K	64.02K	64.02K	418.09K	-236.77K	109.79K
Other Non-Cash Items	8.19M	n/a	-72.57K	-5.62K	n/a	n/a	4.5K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.22M	-290.17K	64.02K	64.02K	418.09K	-236.77K	109.79K
Operating Cash Flow	479.57K	-533.8K	-105.48K	-105.48K	341.3K	-302.3K	24.02K
Capital Expenditures	n/a	-18.82K	n/a	n/a	-18.82K	-18.82K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	57.08K	-19.13K	-19.13K	-57.08K	57.08K	-19.13K
Investing Cash Flow	n/a	38.26K	-19.13K	-19.13K	-75.9K	38.26K	-19.13K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-492.48K	492.48K	128.82K	128.82K	-268.82K	268.82K	n/a
Financial Cash Flow	-492.48K	492.48K	128.82K	128.82K	-268.82K	268.82K	n/a
Net Cash Flow	-12.91K	-3.06K	n/a	-11.17K	-3.42K	4.78K	n/a
Free Cash Flow	479.57K	-495.54K	-105.48K	-105.48K	265.4K	-264.05K	24.02K